Burberry Q1 Retail Revenue Up, Backs FY22 View

Burberry Group plc (BRBY.L) said Friday that its guidance for the fiscal year 2022 remains unchanged, after the retailer posted significant growth in retail revenue for the first quarter, with 1 percent rise in its overall comparable store sales.

The Group's retail revenue for the 13 weeks ended June jumped 86 percent to 479 million pounds, while it rose 98 percent at constant exchange rate.

The Group said it witnessed strong growth across its strategic categories during the quarter, in particular leather goods and outerwear, and exited markdowns in digital and mainline stores.

Looking ahead to the full year, the Group said the medium-term guidance for high single digit top line growth and meaningful margin improvement remains firmly on track. Burberry said it now expects wholesale increase by about 60 percent YoY in the first half due to a stronger order book.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT